Frontiers in Pharmacology | Neuropharmacology

Original Research

Published on 22 May 2025

Mangiferin mitigates neurological deficits and ferroptosis via NRF2/ARE pathway activation in cerebral ischemia-reperfusion rats

in Neuropharmacology

Chenjia Peng
Yang Zhang
Jiaqing Chai
Hengbo Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1577954

Case Report

Published on 21 May 2025

Case Report: Pharmacokinetics of ceftazidime and avibactam during and after CRRT in an elderly patient and their associations with CNS adverse effects

in Neuropharmacology

Haiying Huang
Yun Han
Yinshan Wu
Feng Guo
Zhenwei Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1569715

190 views

Case Report

Accepted on 20 May 2025

Long-Term Clinical Outcomes in RANBP2-Associated Acute Necrotizing Encephalopathy: Report of Two Cases

in Neuropharmacology

Sonia A Varghese
Olutayo I Olubiyi
Irena Dujmovic Basuroski
Jordan Broman-Fulks
Emma B Cardwell
Stephanie Peck
Qian-Zhou (JoJo) Yang
Sheng-Che Hung
Senyene E Hunter

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1607682

Perspective

Published on 20 May 2025

Benzodiazepine use in Spain: risks and perspectives on the current situation and proposals for their rational use

in Neuropharmacology

Carlos Roncero
Lorenzo Armenteros
Carmen Bellido-Cambrón
Amparo Bonilla-Guijarro
Emilio Gómez-Cibeira

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547488

503 views

Original Research

Accepted on 19 May 2025

Comparison of safety of lecanemab and aducanumab: A real-world disproportionality analysis using the FDA adverse event reporting system

in Neuropharmacology

Lingti Kong
Xiaohu Yang
Jian Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1593989

147 views

Study Protocol

Accepted on 19 May 2025

Effects of Intravenous Propofol Combined with Opioids on Euphoria in Patients Undergoing Painless Gastrointestinal Endoscopy: protocol for a randomized double-blind placebo-controlled trial

in Neuropharmacology

Youjia Yu
Yan Li
Qingfang Ma
Fengxia Du
Xiang Zhang
Chunyan Shao
Chuntao Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1599684

Original Research

Accepted on 19 May 2025

Cisplatin induces hippocampal neurotoxicity and cognitive impairment in rats through neuroinflammation, oxidative stress, and overexpression of glutamatergic receptors mRNA

in Neuropharmacology

Ahmad Hamad Alhowail

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1592511

Original Research

Accepted on 19 May 2025

Early statin use might reduce the hemorrhagic transformation among acute ischemic stroke patients with recanalization therapy: a retrospective cohort study

in Neuropharmacology

Boyan Pan
Jiaying Lan
Xiaojun Li
Haoxuan Chen
Luankun Weng
Haoyou Xu
Yuanqi Zhao
Min Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1533905

Review

Accepted on 19 May 2025

Molecular mechanisms of neuroprotective effect of rutin

in Neuropharmacology

Chunmei Zhang
Shuai Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1599167

Review

Published on 19 May 2025

Post stroke depression: pathogenesis and molecular mechanisms of natural product-based interventions

in Neuropharmacology

Haonan Gao
Yanyan Sai
Ruirui Shang
Xia Zhong
Linghui Kong
Jie Liu
Kedong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1595160

289 views

Original Research

Published on 16 May 2025

The regulation and mechanism of the cAMP-PKA pathway on PTSD-like behaviors exacerbated by alcohol exposure

in Neuropharmacology

Shuang Zhao
Wei Zhao
Ziqi Wang
Xiaofei Chen
Fangjiao Zong
Hanting Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1592187

334 views

Original Research

Published on 16 May 2025

Tetramethylpyrazine attenuates the blood-brain barrier damage against ischemic stroke by targeting endothelin-1/Akt pathway in astrocytes

in Neuropharmacology

Minzhen Deng
Yuefang Cai
Yu Wang
Dafeng Hu
Yan Li
Zhenqiu Ning
Chengyi Wang
Sookja Kim Chung
Yan Huang
Jingbo Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571552

279 views

General Commentary

Accepted on 15 May 2025

Commentary: Tauroursodeoxycholic acid regulates macrophage/monocyte distribution and improves spinal microenvironment to promote nerve regeneration through inhibiting NF-κB signaling pathway in spinal cord injury

in Neuropharmacology

Yi Chen
Lei Wu
RUIJIE MA

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1620107

193 views

Review

Accepted on 15 May 2025

Guarding Minds: A Narrative Review on How Antioxidants could shield Sensitive Patients from Antibiotic Neuropsychiatric Toxicity

in Neuropharmacology

Astrid Lounici

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1613152

Original Research

Accepted on 15 May 2025

Association Between SGLT-2 Inhibitors and Suicide Risk in Type 2 Diabetes and Bipolar: A Real-World Cohort Study

in Neuropharmacology

En-Wei Chang
Jing Yang Huang
Shih-Chang Lo
Chien-Ning Huang
Yi-Sun Yang
Edy Kornelius

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1601118

100 views

Original Research

Published on 15 May 2025

Comparative safety analysis of bevacizumab and alkylating agent in glioblastoma management – What have we learned recently?

in Neuropharmacology

Zhizhao Qu
Jiajia Zhao
Liu Yang
Yuanwei Fu
Rui Bai
Jinchuan Li
Hongqin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1595642

285 views